Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S A Sorokin

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Zhurnal Vysshei Nervnoi Deiatelnosti Imeni I P Pavlova|February 26, 2015
[The changes of EEG correlation synchrony at depressive disorder of psychogenic type]A P Kulaichev, A F Iznak, E V Iznak, et al.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|March 3, 2015
[EEG-correlates of frontal dysfunction as predictors of relative pharmacoresistance in treatment of endogenous affective disorders]A F Iznak, E V Iznak, I V Oleĭchik, et al.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|March 16, 2016
[Clinical and therapeutic perspectives of agomelatine (valdoxan) in the treatment of anhedonia in patients with endogenous depressions]G P Panteleeva, L I Abramova, I V Oleichik, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Zhurnal Vysshei Nervnoi Deiatelnosti Imeni I P Pavlova|February 26, 2015
[The changes of EEG correlation synchrony at depressive disorder of psychogenic type]A P Kulaichev, A F Iznak, E V Iznak, et al.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|March 3, 2015
[EEG-correlates of frontal dysfunction as predictors of relative pharmacoresistance in treatment of endogenous affective disorders]A F Iznak, E V Iznak, I V Oleĭchik, et al.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|March 16, 2016
[Clinical and therapeutic perspectives of agomelatine (valdoxan) in the treatment of anhedonia in patients with endogenous depressions]G P Panteleeva, L I Abramova, I V Oleichik, et al.
Pageof 2